Waters Corporation (NYSE:WAT) today introduced a new peptide multi-attribute method (MAM) workflow f

Waters... noitazilaicremmoC dna tnempole

Waters Corporation (NYSE:WAT) today introduced a new peptide multi-attribute method (MAM) workflow for the Waters™ BioAccord™ LC-MS System, enabling drug development, manufacturing, and QC scientists

Visitor, please leave your comment:

© 2025. sitemap